Bank of America Corp (BAC) 16.16 $BAC Bank of America

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Bank of America Corp (BAC) 16.16 $BAC

Bank of America Declares Quarterly Stock Dividends
M2 - 26 mins ago
Bank of America Corporation today announced the Board of Directors declared a regular quarterly cash dividend on Bank of America common stock of $0.05 per share, payable December 24 to shareholders of record as of December 4.
BAC: 16.16 (+0.26)

Merrill Lynch Study on Giving in Retirement Reveals $8 Trillion Longevity Bonus
Business Wire - 38 mins ago
A new Merrill Lynch study reveals a potential giving surge in the United States over the next two decades valued at an estimated $8 trillion, due to the aging baby boomer generation, increasing life expectancy and high rates of giving among retirees. The study, "Giving in Retirement: America's Longevity Bonus" conducted in partnership with Age Wave, found that with more time, savings and skills to contribute to the charities and causes they care about, 65 percent of retirees agree retirement is the best time in life to give back.
BAC: 16.16 (+0.26)

3 Things Bank of America Wants Investors to Know
John Maxfield, The Motley Fool - Motley Fool - 2 hrs 31 mins ago
Bank of America hosted a conference call last week to flush out details of the bank's third-quarter performance. Here are three points that CEO Brian Moynihan emphasized on the call. 1. Bank of America continues to make progress toward its "full...
BAC: 16.16 (+0.26)

Covered Call Alerts For Chipotle Mexican Grill, Horizon Pharma, Abbott Laboratories, Bank of America and Amgen Released By InvestorsObserver
PR Newswire - Thu Oct 22, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for CMG, HZNP, ABT, BAC and AMGN.
ABT: 42.80 (+0.60), CMG: 661.29 (-4.38), HZNP: 13.64 (-1.19), AMGN: 152.26 (+2.17), BAC: 16.16 (+0.26)

Zacks Earnings Trends Highlights: Bank of America
Zacks Equity Research - Zacks Investment Research - Thu Oct 22, 8:30AM CDT
Zacks Earnings Trends Highlights: Bank of America
BAC: 16.16 (+0.26)

SmarTrend Watching for Potential Rebound in Shares of Bank of America After 1.85% Loss
Comtex SmarTrend(R) - Wed Oct 21, 3:49PM CDT
Bank of America (NYSE:BAC) traded in a range yesterday that spanned from a low of $15.90 to a high of $16.29. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $15.98 on volume of 64.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BAC: 16.16 (+0.26)

Look for Shares of Bank of America to Potentially Rebound after Yesterday's 1.85% Sell Off
Comtex SmarTrend(R) - Wed Oct 21, 3:48PM CDT
Bank of America (NYSE:BAC) traded in a range yesterday that spanned from a low of $15.90 to a high of $16.29. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $15.98 on volume of 64.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BAC: 16.16 (+0.26)

3 Takeaways from the Q3 Earnings Season
Sheraz Mian - Zacks Investment Research - Wed Oct 21, 3:13PM CDT
3 Takeaways from the Q3 Earnings Season
BAC: 16.16 (+0.26)

Northern Trust Q3 Earnings Lag Estimates; Revenues up Y/Y
Zacks Equity Research - Zacks Investment Research - Wed Oct 21, 2:35PM CDT
Impacted by elevated expenses, Northern Trust Corporation (NTRS) posted a negative earnings surprise of 1% in the third quarter of 2015. Earnings per share came in at 96 cents, missing the Zacks Consensus Estimate by a penny.
NTRS: 68.61 (+2.06), JPM: 63.48 (+1.42), BAC: 16.16 (+0.26), WFC: 54.36 (+1.24)

Price Collapse Means Hard Times for Alternative Oil Production
at The Street - Wed Oct 21, 2:30PM CDT
And this can have far-reaching implications; banks will feel the pain.
TSLA: 214.68 (+4.59), JPM: 63.48 (+1.42), C: 52.47 (+0.66), WFC: 54.36 (+1.24), BAC: 16.16 (+0.26)

Samsung Pay Is Finally Available For Verizon Customers
Madeleine Johnson - Zacks Investment Research - Wed Oct 21, 1:19PM CDT
Verizon customers have had to wait almost a month to use Samsung Pay since its launch.
T: 34.15 (+0.55), USB: 42.21 (+1.11), S: 4.46 (+0.12), C: 52.47 (+0.66), SYF: 31.61 (-0.85), BAC: 16.16 (+0.26), GOOGL: 682.64 (+10.84), TMUS: 40.62 (+0.40), AAPL: 115.06 (+1.30), VZ: 45.81 (+0.95), USM: 37.61 (+0.58)

Wells Fargo Will Soon Be the Nation’s Third-Biggest Bank by Assets, Overtaking Citigroup
John Maxfield, The Motley Fool - Motley Fool - Wed Oct 21, 10:20AM CDT
Data source: YCharts.com. Chart by author. The financial crisis was the best thing that ever happened to Wells Fargo . By steering clear of the most toxic types of subprime mortgages before the crisis, the California-based bank was able to...
GE: 29.70 (+0.85), C: 52.47 (+0.66), BAC: 16.16 (+0.26), WFC: 54.36 (+1.24)

Accenture, Partnership Fund for NYC and Leading Banks Call for Applicants for New York FinTech Innovation Lab 2016
M2 - Wed Oct 21, 8:22AM CDT
Applications are now being accepted for New York's sixth annual FinTech Innovation Lab, a 12-week program co-founded by Accenture (NYSE: ACN) and the Partnership Fund for New York City that helps early- and growth-stage financial technology (fintech) companies accelerate product and business development by gaining exposure to top bank and venture capital executives. Applications are available at www.fintechinnovationlab.com and are due by Dec. 3.
AXP: 72.45 (-4.06), ALLY: 20.19 (-0.02), C: 52.47 (+0.66), WFC: 54.36 (+1.24), BAC: 16.16 (+0.26), MS: 32.23 (+0.75), GS: 183.46 (+3.76), COF: 76.22 (+2.54), JPM: 63.48 (+1.42), AIG: 61.09 (+0.86), ACN: 106.18 (+3.66)

The 4 Most Important Numbers From Bank of America's 3rd-Quarter Earnings
John Maxfield, The Motley Fool - Motley Fool - Wed Oct 21, 5:35AM CDT
Image credit: Getty Images News/Thinkstock. If you have only a few minutes to assess Bank of America 's third-quarter performance , then the four numbers in the following slideshow will give you a quick but valuable perspective on whether or not...
BAC: 16.16 (+0.26)

5 Things Smart Investors Learned From Wells Fargo's Latest Conference Call
John Maxfield, The Motley Fool - Motley Fool - Tue Oct 20, 4:20PM CDT
Last week, Wells Fargo hosted a conference call to discuss its results for the third quarter. Here are the five most important things the bank's executives wanted investors to know. 1. Operating from a position of strength Because Wells...
GE: 29.69 (+0.84), JPM: 63.48 (+1.42), C: 52.47 (+0.66), BAC: 16.16 (+0.26), WFC: 54.36 (+1.24)

For Shaky Energy Stocks, You Have Options
at The Street - Tue Oct 20, 3:00PM CDT
Price distortion is happening in the energy patch.
AXP: 72.45 (-4.06), CHK: 7.89 (+0.02), C: 52.47 (+0.66), XCO: 1.31 (+0.03), SN: 7.46 (+0.06), BAC: 16.16 (+0.26), WFC: 54.36 (+1.24)

Bank of America Is Getting Better, Not Bigger
John Maxfield, The Motley Fool - Motley Fool - Tue Oct 20, 1:20PM CDT
In 2011, a little over a year after taking the helm at Bank of America , CEO Brian Moynihan predicted that the nation's second-biggest bank by assets would earn between $22 billion and $24 billion a year after the effects of the financial crisis...
BAC: 16.16 (+0.26)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Beta Bionics Hit with Lawsuit Over Misleading Claims

Updated Category News Views 6

Unpacking Beta Bionics' Legal Storm Investors in Beta Bionics, Inc. —ticker BBNX—are probably feeling like they're caught in a whirlwind right now, and who can blame them? The company's facing a class action lawsuit, and the accusations aren't anything to sniff at. They're talking about violations of the Securities Exchange Act of 1934, along with some shady...

Continue Reading
Mountain Living: Facing the Population Growth Crunch

Updated Category News Views 0

Population Growth Reshaping U.S. Mountain Communities Living in a picturesque mountain town used to offer an idyllic escape from the hustle and bustle of city life. But now, even these scenic enclaves are feeling the squeeze from a wave of population growth that's hard to ignore. Mark Cromer tackles this head-on in his new Forum paper, 'The Long Goodnight of Rocky...

Continue Reading
Kenneth Spells: Championing Education Leadership in 2026

Updated Category News Views 3

Out there in Hoke County, you’ve got a man named Kenneth Spells shaking things up the way a strong leader should. Now, you know I’m not here to fluff up anyone’s feathers—especially in an arena as aching for reform as education. But credit where credit’s due, Spells picked up the ‘2026 Professional of the Year’ from The Inner Circle for a reason, and it’s...

Continue Reading
XTI Aerospace Eyes Growth Amid Revenue Slip

Updated Category News Views 4

A Second Quarter Snapshot Ah, the world of aerospace—where soaring ambitions often face a reality check. XTI Aerospace, hitching a ride on the drone tech boom, found itself dealing with a mixed bag this past second quarter. Coming from the streets of Miami with its quarterly numbers, XTI's interim CEO Jeremy Schneiderman is banking on drones to lift their revenue skies....

Continue Reading
DICK'S Sporting Goods Faces Legal Challenges in Securities Suit

Updated Category News Views 4

Trouble Brewing at DICK'S Sporting Goods Wall Street's not only about the wins. There are moments when the market throws a curveball, and right now, DICK'S Sporting Goods is facing a fast one. DJS Law Group just laid out a class action lawsuit accusing them of bending the securities law rules. It ain't pretty when a company gets tangled up in legal battles, but it's...

Continue Reading
Meitav Tops 2025 Service Index with Stellar Growth

Updated Category News Views 6

Meitav’s Leap to The Summit Damn, it's a wild market when a pension fund provider snatches the crown. But here we are, looking at Meitav Provident Funds and Pension Ltd., standing proudly as Israel's top dog in the 2025 Service Index for pension funds. We're talking a jump from fourth to numero uno, folks, with a hefty score of 83 out of 100. And don't sleep on their...

Continue Reading
CAR T-Cell Therapy Offers New Hope for SPS Patients

Updated Category News Views 0

Game-changing Developments in CAR T-Cell Therapy Leaping straight into the meat of it—our friends at the University of Colorado Anschutz are onto something big. They've wrapped up a study pushing the boundaries of CAR T-cell therapy, and let me tell you, it looks like a real game-changer for those battling the rare beast known as stiff person syndrome (SPS). Breaking...

Continue Reading
Software Tax Hits Enterprises: Costly Control Concerns

Updated Category News Views 16

Unanticipated Software Costs: Who's in Charge? Picture this: you're running a tech setup at a major corporation, but the software changes thrust upon you aren't anything you would've chosen freely. Yeah, that's about one in four dollars from your hot little budget spent on tweaks and adjustments you didn’t ask for. And it's not as glamorous as it sounds—more like a...

Continue Reading
Jackson Hewitt Aims to Recruit 15,000 Seasonal Staff

Updated Category News Views 8

Revving Up for Tax Season: Jackson Hewitt's Hiring Push When tax season looms, the hustle can't be understated, and Jackson Hewitt is cranking it up by hunting for 15,000 new recruits to tackle this annual financial circus. Starting October 26, this hiring fest is open season across the nation, pulling out all the stops to bolster its workforce. But what does this mean...

Continue Reading
Tax Strategy Crucial: Sidnell & Webster of Lufkin Weigh In

Updated Category News Views 4

Breaking Down Tax Prep vs. Planning Ever wonder why some folks never break a sweat come tax season, while others scramble like their hair's on fire? It all boils down to understanding two very different animals: tax preparation and tax planning. CPA veterans Yvette Sidnell and Jennifer Webster over in Lufkin, Texas, have laid it out crystal clear in their article with...

Continue Reading

Top 5 Most Recently Viewed Articles

Rancho Mission Viejo: Leading the Way in Wellness Real Estate

Updated Category News Views 202

Rancho Mission Viejo Recognized Globally for Wellness Development The Ranch stands out as a model for wellness communities and showcases the impact on individual lives. This 23,000-acre master-planned community and functional cattle ranch has achieved global recognition as one of the largest intentional wellness real estate developments. A Testament to Community Design As...

Continue Reading
Revolutionizing Patient Access with AI: The New Trial Finder

Updated Category News Views 177

Introducing the Future of Clinical Trials The world of radiopharmaceuticals is changing rapidly, with an innovative new tool set to revolutionize the way patients and healthcare providers access critical information about clinical trials. The Radiopharmaceutical Trial Finder, backed by the ICPO Foundation, was developed through a collaboration between WARMTH and...

Continue Reading
Semler Scientific Faces Legal Challenges Amid Controversy

Updated Category News Views 157

Semler Scientific Under Legal Scrutiny Semler Scientific, Inc. is currently facing a class action lawsuit that sheds light on serious allegations regarding their securities practices. Shareholders of the company, identified by the ticker SMLR, are encouraged to be proactive amidst these developments. The lawsuit primarily alleges violations of federal securities exchanges...

Continue Reading
Charles Dayoub Joins The Willis Law Group Fraud Team

Updated Category News Views 207

Charles Dayoub Enhances The Willis Law Group’s Fraud Team We are delighted to announce that Charles Dayoub has joined The Willis Law Group P.L.L.C., bringing with him a wealth of experience with over 18 years in law and extensive expertise in executive positions. His previous role at a prominent law firm involved dealing with government receivables and regulatory...

Continue Reading
Evaluating Revolution Medicines' Future Potential and Progress

Updated Category News Views 168

Revolution Medicines Maintains Positive Outlook Piper Sandler has sustained an optimistic outlook regarding Revolution Medicines (NASDAQ: RVMD), reaffirming its Overweight rating with a specified price target of $57.00. This commitment to the stock's rating comes after recent developments linked to the company’s Phase I trial, which is focused on RMC-6236, a potential...

Continue Reading